The Impact of Biologic and Targeted Synthetic Disease Modifying Drugs in Psoriatic Arthritis

Project: UK industry

Project Details

StatusNot started

Research Output

  • 3 Article
  • 3 Other contribution
  • 2 Meeting abstract

AB0756 GUSELKUMAB IMPROVED WORK PRODUCTIVITY AND DAILY ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 3 TRIAL

Curtis, J., Mcinnes, I., Rahman, P., Tillett, W., Mease, PJ., Kollmeier, A., Hsia, EC., Zhou, B., Agarwal, P. & Peterson, S., 1 May 2020, BMJ Publishing Group Ltd.

Research output: Other contribution

AB0811 DEMOGRAPHIC, TREATMENT AND DISEASE CHARACTERISTICS OF PATIENTS WITH PSORIATIC ARTHRITIS RECEIVING TOFACITINIB IN THE UNITED STATES, FRANCE, GERMANY, ITALY, SPAIN AND THE UNITED KINGDOM

Ogdie, A., Schmerold, L., Tillett, W., Germino, R., Cappelleri, JC. & Young, P., 1 May 2020, BMJ Publishing Group Ltd.

Research output: Other contribution